Treatment of Sclerosing Mesenteritis in Chronic Ischemia Caused by Mesenteric Vascular Obstruction

Clinical Scenario

Sclerosing mesenteritis presenting alongside chronic ischemia caused by mesenteric vascular obstruction represents a particularly complex management challenge. The coexisting vascular compromise affects how treatment options can be applied.

Condition Context

Patients with chronic ischemia caused by mesenteric vascular obstruction are considered for revascularization as part of their management. Both the anatomical characteristics of the vascular lesion and the extent of the inflammatory mesenteric disease shape which interventions are feasible.

Treatment Approach

Revascularization is the primary consideration in this setting — whether by endovascular or surgical means — though candidacy for each approach is substantially limited by disease-specific factors. Additional therapeutic options have also been evaluated with variable outcomes. The complete structured regimen, including the assessment algorithm and all available options, is in the full protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.cgh.2024.12.025

Patients with chronic ischemia caused by mesenteric vascular obstruction are considered for revascularization.
Few are candidates for endovascular revascularization because of the long length or distal location of the vessel.
Surgical mesenteric revascularization is rarely feasible because of the extensive inflammatory disease.
Radiation therapy has had equivocal success.

View source ↗